Kengo Sato

Years Active: 2019-2020
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Koichiro Shibata, Kengo Sato, Remina Shirai, Tomomi Seki, Taisuke Okano, Tomoyuki Yamashita, Ayaka Koide, Mutsumi Mitsuboshi, Yusaku Mori, Tsutomu Hirano, Takuya Watanabe
Lipocalin-2 exerts pro-atherosclerotic effects as evidenced by in vitro and in vivo experiments. Heart and vessels 35 (7) (2020)
Taisuke Okano, Kengo Sato, Remina Shirai, Tomomi Seki, Koichiro Shibata, Tomoyuki Yamashita, Ayaka Koide, Hitomi Tezuka, Yusaku Mori, Tsutomu Hirano, Takuya Watanabe
β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques. International journal of endocrinology 2020 (2020)
Kengo Sato, Hayami Yoshizawa, Tomomi Seki, Remina Shirai, Tomoyuki Yamashita, Taisuke Okano, Koichiro Shibata, Miyu J Wakamatsu, Yusaku Mori, Toshisuke Morita, Taka-Aki Matsuyama, Hatsue Ishibashi-Ueda, Tsutomu Hirano, Takuya Watanabe
Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis. Clinical science (London, England : 1979) 133 (16) (2019)

Kengo Sato.css-eqlu8i{font-size:small;padding-left:4px;}